Randomized Study of the Efficacy and Safety of a Single Dose of Synvisc-One® in Chinese Patients With Symptomatic Osteoarthritis of the Knee

NCT03190369 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

440

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis

Interventions

DEVICE: Hylan G-F 20 (GZ402662/SAR402662)
DRUG: Placebo

Sponsor

Genzyme, a Sanofi Company